Skip to main content
. 2023 Mar 2;11(3):578. doi: 10.3390/vaccines11030578

Table 2.

Experimental vaccines using Capripoxvirus as a live virus vector.

Target Pathogen Antigen Expressed Capripoxvirus Backbone Reference
Rindepest Virus Rindepest Virus H and F gene KS-1 * [122]
Peste-des-petits-ruminants virus (PPRV) hemagglutinin (H) or the fusion (F) protein gene of PPRV KS-1 * [118]
Blue Tongue Virus (BTV) BTV VP7 KS-1 * [119]
Rift Valley Fever Virus (RVFV) RVFV Gn and Gc glycoproteins KS-1 * [117]
HIV Grttn polyprotein nLSDV [106,123]
Env and Gag nLSDV with SODis [105]
Rabies virus (RABV) RABV Glycoprotein nLSDV [6]
Mokola virus (MOKV), West Caucasian bat virus (WCBV), Rabies Virus (RABV) RABV, MOKV and WCBV glycoprotein genes nLSDV [121]
Rift valley fever virus (RVFV) RVFV Gn and Gc glycoproteins nLSDV [102,124,125]
Bovine ephemeral fever virus (BEFV) BEFV Glycoprotein nLSDV [102,124,125]
Glycoprotein nLSDV with either SODis or ΔSOD [104]
Glycoprotein and Matrix

nLSDV: Neethling strain of LSDV; SODis: stabilised superoxide dismutase gene; ΔSOD: deleted superoxide dismutase gene. * KS-1 was originally thought to be of SPPV origin, but sequencing revealed that it was actually an LSDV derived vaccine [120].